AMIM
GSK icon

Aull & Monroe Investment Management’s GSK GSK Stock Holding History

Aull & Monroe Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Hold
6,408
– – 0.14% 100
2026
Q1 		$354K Hold
6,408
– – 0.16% 94
2025
Q4 		$314K Sell
6,408
-80
-1% -$3.73K 0.16% 98
2025
Q3 		$280K Hold
6,488
– – 0.14% 102
2025
Q2 		$249K Sell
6,488
-160
-2% -$6.11K 0.13% 111
2025
Q1 		$258K Sell
6,648
-480
-7% -$17.6K 0.13% 112
2024
Q4 		$241K Sell
7,128
-1,624
-19% -$58.5K 0.12% 113
2024
Q3 		$358K Sell
8,752
-560
-6% -$22.9K 0.17% 101
2024
Q2 		$359K Sell
9,312
-2,556
-22% -$108K 0.18% 99
2024
Q1 		$509K Sell
11,868
-442
-4% -$18.2K 0.23% 86
2023
Q4 		$456K Sell
12,310
-599
-5% -$21.5K 0.23% 85
2023
Q3 		$468K Sell
12,909
-54
-0.4% -$1.92K 0.24% 84
2023
Q2 		$462K Hold
12,963
– – 0.23% 88
2023
Q1 		$461K Sell
12,963
-240
-2% -$8.4K 0.23% 84
2022
Q4 		$464K Sell
13,203
-320
-2% -$10.7K 0.23% 82
2022
Q3 		$398K Sell
13,523
-321
-2% -$12.2K 0.22% 85
2022
Q2 		$753K Hold
13,844
– – 0.38% 64
2022
Q1 		$753K Hold
13,844
– – 0.34% 68
2021
Q4 		$763K Sell
13,844
-400
-3% -$20.8K 0.34% 69
2021
Q3 		$680K Hold
14,244
– – 0.34% 71
2021
Q2 		$709K Sell
14,244
-720
-5% -$34.6K 0.34% 72
2021
Q1 		$668K Sell
14,964
-560
-4% -$25.4K 0.33% 71
2020
Q4 		$714K Sell
15,524
-1,047
-6% -$48.1K 0.38% 69
2020
Q3 		$779K Sell
16,571
-560
-3% -$28.1K 0.46% 61
2020
Q2 		$873K Sell
17,131
-560
-3% -$28.7K 0.54% 58
2020
Q1 		$838K Sell
17,691
-40
-0.2% -$2.13K 0.56% 52
2019
Q4 		$1.04M Hold
17,731
– – 0.53% 60
2019
Q3 		$946K Sell
17,731
-80
-0.4% -$4.12K 0.5% 59
2019
Q2 		$891K Buy
17,811
+1,018
+6% +$51.1K 0.47% 64
2019
Q1 		$877K Sell
16,793
-800
-5% -$40K 0.47% 66
2018
Q4 		$840K Sell
17,593
-1,600
-8% -$78.8K 0.48% 64
2018
Q3 		$963K Buy
19,193
+160
+0.8% +$8.13K 0.46% 64
2018
Q2 		$959K Buy
19,033
+609
+3% +$30.7K 0.49% 66
2018
Q1 		$900K Buy
18,424
+160
+0.9% +$7.45K 0.47% 69
2017
Q4 		$809K Sell
18,264
-2,000
-10% -$92.4K 0.41% 75
2017
Q3 		$1.03M Hold
20,264
– – 0.53% 63
2017
Q2 		$1.09M Hold
20,264
– – 0.58% 57
2017
Q1 		$1.07M Buy
20,264
+560
+3% +$28.4K 0.57% 58
2016
Q4 		$949K Sell
19,704
-160
-0.8% -$7.9K 0.53% 62
2016
Q3 		$1.07M Sell
19,864
-240
-1% -$13.2K 0.62% 56
2016
Q2 		$1.09M Buy
20,104
+21
+0.1% +$1.11K 0.63% 54
2016
Q1 		$1.02M Buy
20,083
+951
+5% +$47.4K 0.61% 58
2015
Q4 		$965K Buy
19,132
+760
+4% +$38.7K 0.6% 59
2015
Q3 		$883K Sell
18,372
-134
-0.7% -$6.97K 0.57% 61
2015
Q2 		$999K Buy
18,506
+1,602
+9% +$90.2K 0.59% 62
2015
Q1 		$975K Buy
16,904
+2,720
+19% +$156K 0.55% 67
2014
Q4 		$757K Buy
14,184
+1,640
+13% +$91.8K 0.41% 74
2014
Q3 		$721K Buy
+12,544
New +$769K 0.38% 74

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM

Aull & Monroe Investment Management's GSK Position: Q2 2026 in Review

Aull & Monroe Investment Management held its GSK (GSK) position steady in Q2 2026 at 6,408 shares worth $336K. The position accounts for 0.14% of the portfolio, ranked #100.

Aull & Monroe Investment Management first reported a position in GSK in Q3 2014 and has held it in 48 quarters since. The position peaked at $1.09M in Q2 2017. 296 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Aull & Monroe Investment Management held 6,408 shares of GSK worth $336K as of Q2 2026.
  • Aull & Monroe Investment Management left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.14% of Aull & Monroe Investment Management's portfolio in Q2 2026, its #100 holding.
  • Aull & Monroe Investment Management first reported a position in GSK in Q3 2014 and has held it in 48 quarters since.
  • Aull & Monroe Investment Management's GSK position peaked at $1.09M in Q2 2017.
  • 296 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Aull & Monroe Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.